• Home
  • Science&Technology
    • Research Areas
    • Technology Platform
  • Products
    • Product Center
    • Pipeline Progress
  • Media News
    • Press_releases
    • Media_Images
  • IR
    • Fact Sheet
    • Ir Calendar
    • Interactive Analysis Tool
    • Share Graph
    • Share Price Alters
    • Annual Report Download
    • Lost Share Certificate
    • Announcements & Circulars
    • Email Subscription Center
    • Faqs
    • Dissemination of Corporate Communications
  • About Us
    • Profile
    • Leadership
    • Partnering
    • CSR
    • IP
    • Honor
EN 简 繁

Media

PRESS RELEASES

Home

Media

PRESS RELEASES

  • Uni-Bio Science Announces 2024 Annual Results

    Uni-Bio Science Announces 2024 Annual Results

    ​Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8M,First-ever Dividend was HK$0.277 Cents Per Share,Strengthening Presence in Osteoporosis,Ophthalmology, and Aesthetic Medical Markets

    2025-03-27

    View details
  • Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High-Growth Medical Aesthetics Market

    Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High-Growth Medical Aesthetics Market

    ​2nd December 2024 –Uni-Bio Science Group Limited is pleased to announce two significant milestones that demonstrate the Group’s continued growth and innovation in the field of medical aesthetics and dermatological solutions.

    2024-12-02

    View details
  • Uni-Bio Science Announces 2024 Interim Results

    Uni-Bio Science Announces 2024 Interim Results

    ​Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M Further Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets

    2024-08-28

    View details
  • Uni-Bio Science And Chongqing Minji Establish Strategic Partnership, Targeting Hundreds Of Billions Of Yuan of Medical Aesthetics Device Market

    Uni-Bio Science And Chongqing Minji Establish Strategic Partnership, Targeting Hundreds Of Billions Of Yuan of Medical Aesthetics Device Market

    ​Recently, Uni-Bio Science Group Limited is pleased to announce a strategic cooperation with Chongqing Minji Medical Device Co., Ltd.

    2024-07-10

    View details
  • Uni-Bio Science Announces 2023 Annual Results

    Uni-Bio Science Announces 2023 Annual Results

    ​Record-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M,Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets

    2024-03-28

    View details
  • 1
  • 2
  • 3
  • 4
  • 5
  • >>
  • 17
Hot news
  • 2024-01-22
    As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)
  • 2020-09-18
    Uni-Bio Science Group’s Uni-GLP Developmental Potential in Treatment of COVID-19 and Other Indications
  • 2020-11-13
    Uni-Bio Science Group Chairman Awarded “Young Industrialist of Hong Kong 2020”
  • 2021-09-01
    Uni-Bio Science Group and Alephoson Biopharmaceuticals Announce Partnership to Co-Develop Next-generation Best-in-class Compounds
  • 2020-05-14
    Uni-Bio Science Group and Medlink Builds Strategic Partnership,Expansion of Value Chain towards Pharmaceutical E-commerce
  • Contact
  • Message
HK Uni-Bio Science Group
(852)31023232 info@uni-bioscience.com Unit 502, 5/F, No. 20 Science Park East Avenue,Hong Kong Science Park,Shatin, New Territories, Hong Kong
Shenzhen Watsin
(0755)21376639 info.ws@uni-bioscience.com No.7 Science Middle 1st Road, Nanshan District, Shenzhen City
Uni-Bio YongTai
(010)80117799-8025 info.hc@uni-bioscience.com 1105, 10th floor, building 3, yard 93, Jianguo Road, Chaoyang District, Beijing
Beijing Genetech
(010)80117799 info.gt@uni-bioscience.com No.7 Xinghuo Street, Changping Sector of Zhongguancun Science Park, Changping District, Beijing
Follow Us

Copyright ©2025 Uni-Bio Science Group Ltd.京公网安备 11011402013046号京ICP备17029593号-2